Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease
Effect of Scenario-Based Reenactment Training on Orientation Impairment in Patients With Mild to Moderate Alzheimer' s Disease
1 other identifier
interventional
126
1 country
1
Brief Summary
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, including impairments in orientation, memory, and daily functioning. Orientation dysfunction, involving difficulties in recognizing time, place, and person, is a common and clinically significant feature in patients with mild to moderate AD. This study aims to evaluate the effectiveness of a scenario-based reenactment training program in improving cognitive function and orientation ability in patients with mild to moderate Alzheimer's disease. The intervention is based on patients' real-life experiences and uses personalized visual materials (e.g., photos and videos) to reconstruct familiar scenarios, thereby enhancing cognitive stimulation and environmental recognition. In this prospective controlled study, participants will be assigned to either a scenario-based training group or a usual care group. The intervention group will receive structured training sessions three times per week for 3 months, followed by a 6-month follow-up period. The control group will receive standard care without structured cognitive training. The primary outcome is global cognitive function assessed by the Montreal Cognitive Assessment (MoCA). Secondary outcomes include orientation function, depressive symptoms, anxiety levels, quality of life, and intervention feasibility. This study aims to provide evidence for a practical, non-pharmacological intervention to improve cognitive and functional outcomes in patients with Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2026
CompletedFirst Posted
Study publicly available on registry
April 23, 2026
CompletedApril 23, 2026
April 1, 2026
12 months
April 14, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global Cognitive Function Assessed by Montreal Cognitive Assessment (MoCA)
Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a validated 30-point scale ranging from 0 to 30, with higher scores indicating better cognitive performance. The MoCA evaluates multiple cognitive domains including attention, executive function, memory, language, visuospatial ability, and orientation.
Baseline and 3 months after intervention
Secondary Outcomes (7)
Orientation Function Assessed by MoCA Orientation Subscore
Baseline and 3 months after intervention
Depressive Symptoms Assessed by GDS-15
Baseline and 3 months after intervention
Anxiety Levels Assessed by GAI-20
Baseline and 3 months after intervention
Cognitive Outcome Transitions
Baseline to 3 months
Intervention Adherence
During the 3-month intervention period
- +2 more secondary outcomes
Study Arms (2)
Scenario-Based Reenactment Training
EXPERIMENTALParticipants receive structured scenario-based reenactment training in addition to usual care. The intervention is based on patients' real-life experiences and utilizes personalized visual materials such as photographs and videos to reconstruct familiar scenarios. Training is conducted three times per week for 3 months, with each session lasting approximately 30-45 minutes. The program targets temporal, spatial, and person orientation to improve cognitive function.
Usual Care
ACTIVE COMPARATORParticipants receive standard medical and nursing care without structured cognitive intervention. Routine care includes pharmacological treatment, basic nursing support, and general health education.
Interventions
Scenario-based reenactment training is a structured, personalized cognitive intervention designed to improve orientation and cognitive function in patients with Alzheimer's disease. The intervention is based on patients' real-life experiences and utilizes individualized visual materials, such as photographs and videos, to reconstruct familiar temporal, spatial, and interpersonal scenarios. Participants engage in guided recognition, recall, and contextual judgment tasks targeting orientation domains (time, place, and person). The intervention is delivered three times per week for 3 months, with each session lasting approximately 30-45 minutes. Training is conducted by trained healthcare providers or caregivers, both in hospital and home settings, with ongoing supervision to ensure consistency and adherence.
Participants receive standard medical and nursing care without structured cognitive intervention. Routine care includes pharmacological treatment, basic nursing support, and general health education.
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years
- Diagnosis of mild to moderate Alzheimer's disease according to DSM-5 criteria
- Ability to communicate and complete cognitive assessments
- Stable caregiver available to assist with intervention and follow-up
- Visual and auditory function adequate to participate in assessments (with or without correction)
- Willingness to participate and provide informed consent (by patient or legal guardian)
You may not qualify if:
- Severe psychiatric disorders (e.g., severe depression, schizophrenia)
- Severe cardiovascular, cerebrovascular, or other systemic diseases affecting participation
- History of neurological disorders other than Alzheimer's disease (e.g., Parkinson's disease, stroke with major deficits)
- Severe sensory impairment (vision or hearing) that interferes with intervention or assessment
- Inability to complete study procedures or comply with follow-up
- Participation in other interventional clinical trials within the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tongde Hospital of Zhejiang Province
Hangzhou, Zhejiang, 310012, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to group allocation to minimize assessment bias. Participants and care providers were not blinded due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Department of Neurology
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 23, 2026
Study Start
January 1, 2024
Primary Completion
December 30, 2024
Study Completion
June 30, 2025
Last Updated
April 23, 2026
Record last verified: 2026-04